Pregnancy Outcomes in Multiple Sclerosis Populations Exposed and Unexposed to Interferon β - a Register-based Study in the Nordic Countries
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Interferon beta-1b (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bayer
- 14 Jun 2017 Planned End Date changed from 30 Apr 2017 to 30 Oct 2017.
- 14 Jun 2017 Planned primary completion date changed from 30 Apr 2017 to 30 Oct 2017.
- 10 Jun 2017 Biomarkers information updated